Indian scientists have developed a new class of synthetic peptides that can not only block the entry of the SARS-CoV-2 virus into cells but also clump the virus particles together, reducing their ability to infect the living cell.
This novel mechanism provides an alternative to make viruses like SARS-CoV-2 inactive, promising a new class of peptides as antivirals. Scientists at the Indian Institute of Science in collaboration with researchers from the CSIR-Institute of Microbial Technology have exploited this approach to design these peptides.
